Advertisement

Reflux and Aspiration: Their Presumed Role in Chronic Cough and the Development of End-Stage Lung Disease

  • Jacob A. Klapper
  • Brian Gulack
  • Matthew G. Hartwig
Chapter

Abstract

Amongst patients with end-stage lung disease (ESLD), symptoms and diagnostic evidence of gastroesophageal reflux disease (GERD) are extremely common. In fact, roughly two-thirds of all patients with ESLD have documentable gastroesophageal reflux [1]. The presence of significant reflux is not limited to one pulmonary disease, but is seen in patients with ESLD secondary to COPD, cystic fibrosis and idiopathic pulmonary fibrosis (IPF) [2] (Gasper et al. 2007). While the pathophysiology of COPD and cystic fibrosis are well understood, it remains unknown what leads to the eventual development of IPF. Interestingly, evidence has continued to mount over the last 20 years that reflux is not just prevalent in patients with IPF, but may in fact be contributing to its development.

References

  1. 1.
    D’Ovidio F, Singer L, Hadjiliadis D, et al. Prevalence of gastroesophageal reflux in end-stage lung disease candidates for lung transplant. Ann Thorac Surg. 2005;80:1254–61.CrossRefPubMedGoogle Scholar
  2. 2.
    Sweet M, Herbella F, Leard L, et al. The prevalence of distal and proximal gastroesophageal reflux in patients awaiting lung transplantation. Ann Surg. 2006;244:491–7.PubMedPubMedCentralGoogle Scholar
  3. 3.
    Gasper W, Sweet M, Golden J, et al. Lung transplantation in patients with connective tissue disorders and esophageal dysmotility. Dis Esophagus. 2008;21:650–5.CrossRefPubMedGoogle Scholar
  4. 4.
    Reid K, McKenzie F, Menkis A, et al. Importance of chronic aspiration in recipients of heart-lung transplants. Lancet. 1990;336:206–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Rinaldi M, Martinelli L, Volpato G, et al. Gastroesophageal reflux as a cause of obliterative bronchiolitis: a case report. Transplant Proc. 1995;27:2006–7.PubMedGoogle Scholar
  6. 6.
    Hartwig M, Anderson D, Onaitis M, et al. Fundoplication after lung transplantation prevents the allograft dysfunction associated with reflux. Ann Thorac Surg. 2011;92:462–9.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Birring S. Controversies in the evaluation and management of chronic cough. Am J Respir Crit Care Med. 2010;183:709–15.Google Scholar
  8. 8.
    Fathi H, Wright C, Thompson R, et al. Chronic cough and esomeprazole: a double-blind placebo-controlled parallel study. Respirology. 2011;16:1150–6.CrossRefPubMedGoogle Scholar
  9. 9.
    Mastronarde J, Anthonisen N, Castro M, et al. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med. 2009;360:1487–99.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Irwin R, Baumann M, Bolser D, et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006;129:1S–23S.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Patti M, Tedesco P, Golden J, et al. Idiopathic pulmonary fibrosis: how often is it really idiopathic? J Gastrointest Surg. 2005;9:1053–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Raghu G. The role of gastroesophageal reflux in idiopathic pulmonary fibrosis. Am J Med. 2003;115:60S–4S.CrossRefPubMedGoogle Scholar
  13. 13.
    Glauser FL, Millen JE, Falls R, et al. Increased alveolar epithelial permeability with acid aspiration: the effects of high-dose steroids. Am Rev Respir Dis. 1970;120:1119–23.Google Scholar
  14. 14.
    Salley S, Santo G, Barnhart M, et al. Immediate histopathology of hydrocholoric acid aspiration. Scan Electron Microsc. 1970;3:911–20.Google Scholar
  15. 15.
    Schwartz D, Wynne J, Gibbs C, et al. The pulmonary consequences of aspiration of gastric contents at pH values greater than 2.5. Am Rev Respir Dis. 1980;121:119–26.PubMedGoogle Scholar
  16. 16.
    el-Serag HB, Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology. 1997;113:755–60.CrossRefPubMedGoogle Scholar
  17. 17.
    Mays E, Dubois J, Hamilton G, et al. Pulmonary fibrosis associated with tracheobronchial aspiration: a study of the frequency of hiatal hernia and gastroesophageal reflux in interstitial pulmonary fibrosis of obscure etiology. Chest. 1976;69:512–5.CrossRefPubMedGoogle Scholar
  18. 18.
    Sweet M, Patti M, Leard L, et al. Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation. J Thorac Cardiovasc Surg. 2007;133:1078–84.CrossRefPubMedGoogle Scholar
  19. 19.
    Beck-Schimmer B, Bonvini J. Bronchoaspiration: incidence, consequences and management. Eur J Anaesthesiol. 2011;28:78–84.CrossRefPubMedGoogle Scholar
  20. 20.
    Hu X, Lee J, Pianosi P, et al. Aspiration-related pulmonary syndromes. Chest. 2015;147:815–23.CrossRefPubMedGoogle Scholar
  21. 21.
    Marik P. Pulmonary aspiration syndromes. Curr Opin Pulm Med. 2011;17:148–54.CrossRefPubMedGoogle Scholar
  22. 22.
    Kennedy T, Johnson K, Kunkel R, et al. Acute acid aspiration lung injury in the rat: biphasic pathogenesis. Anesth Analg. 1989;69:87–92.PubMedGoogle Scholar
  23. 23.
    Madjdpour L, Kneller S, Booy C, et al. Acid-induced lung injury: role of nuclear factor-κB. Anesthesiology. 2003;99:1323–32.CrossRefPubMedGoogle Scholar
  24. 24.
    Appel J, Lee S, Hartwig M, et al. Characterization of the innate response to chronic aspiration in a novel rodent model. Respir Res. 2007;8:87.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Tobin R, Pope C, Pellegrini C, et al. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 1998;158:1804–8.CrossRefPubMedGoogle Scholar
  26. 26.
    Raghu G, Freudenberger T, Yang S, et al. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis. Eur Respir J. 2006;27:136–42.CrossRefPubMedGoogle Scholar
  27. 27.
    Lee J, Collard H, Raghu G, et al. Does chronic microaspiration cause idiopathic pulmonary fibrosis. Am J Med. 2010;123:304–11.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Lee J, Ryu J, Elicker B, et al. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2011;184:1390–4.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Linden P, Gilbert R, Yeap B, et al. Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. J Thorac Cardiovasc Surg. 2006;131:438–46.CrossRefPubMedGoogle Scholar
  30. 30.
    Young L, Hadjiliadis D, Davis D, et al. Lung transplantation exacerbates gastroesophageal reflux disease. Chest. 2003;124:1689–93.CrossRefPubMedGoogle Scholar
  31. 31.
    Li B, Hartwig M, Appel J, et al. Chronic aspiration of gastric fluid induces the development of obliterative bronchiolitis in rat lung transplants. Am J Transplant. 2008;8:1614–21.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Palmer S, Miralles A, Howell D, et al. Gastresophageal reflux as a reversible cause of allograft dysfunction after lung transplantation. Chest. 2000;118:1214–7.CrossRefPubMedGoogle Scholar
  33. 33.
    Blondeau K, Mertens V, Vanaudenaerde B, et al. Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection. Eur Respir J. 2008;31:707–13.CrossRefPubMedGoogle Scholar
  34. 34.
    Fisichella P, Davis C, Gagermeier J, et al. Laparoscopic antireflux surgery for gastroesophageal reflux disease after lung transplantation. J Surg Res. 2011;170:e279–86.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Fisichella P, Davis C, Lundberg P, et al. The protective role of laparoscopic antireflux surgery against aspiration of pepsin after lung transplantation. Surgery. 2011;150:598–606.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Stovold R, Forrest I, Corris P, et al. Pepsin, a biomarker of gastric aspiration in lung allografts. Am J Respir Crit Care Med. 2007;175:1298–303.CrossRefPubMedGoogle Scholar
  37. 37.
    Shah N, Force S, Mitchell P, et al. Gastroesophageal reflux disease is associated with an increased rate of acute rejection in lung transplant allografts. Transplant Proc. 2010;42:2702–6.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Ward C, Forrest I, Brownlee I, et al. Pepsin like activity in bronchoalveolar lavage fluid is suggestive of gastric aspiration in lung allografts. Thorax. 2005;60:872–4.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    D’Ovidio F, Mura M, Ridsdale R, et al. The effect of reflux and bile acid aspiration on the lung allograft and its surfactant and innate immunity molecules of SP-A and SP-D. Am J Transplant. 2006;6:1930–8.CrossRefPubMedGoogle Scholar
  40. 40.
    Berkowitz N, Shulman L, McGregor C, et al. Gastroparesis after lung transplantation: potential role in postoperative respiratory complications. Chest. 1995;108:1602–7.CrossRefPubMedGoogle Scholar
  41. 41.
    Bhashyam A, Mogayzel P, Cleary J, et al. Vagal control of mucociliary clearance in murine lungs: a study in a chronic preparation. Auton Neurosci. 2010;154:74–8.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Pazetti R, Pêgo-Fernandes P, Jatene F. Adverse effects of immunosuppressant drugs upon airway epithelial and mucociliary clearance: implications for lung transplant recipients. Drugs. 2013;73:1157–69.CrossRefPubMedGoogle Scholar
  43. 43.
    Fisichella P, Davis C, Lowery E, et al. Pulmonary immune changes early after laparoscopic antireflux surgery in lung transplant patients with gastroesophageal reflux disease. J Surg Res. 2012;177:e65–73.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Cantu E, Appel J, Hartwig M, et al. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg. 2004;78:1142–51.CrossRefPubMedGoogle Scholar
  45. 45.
    Robertson A, Krishman A, Ward C, et al. Anti-reflux in lung transplant recipients: outcomes and effects on quality of life. Eur Respir J. 2012;39:691–7.CrossRefPubMedGoogle Scholar
  46. 46.
    Hoppo T, Jarido V, Pennathur A, et al. Antireflux surgery preserves lung function in patients with gastroesophageal reflux disease and end-stage lung disease before and after lung transplantation. Arch Surg. 2011;146:1041–7.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Jacob A. Klapper
    • 1
  • Brian Gulack
    • 1
  • Matthew G. Hartwig
    • 1
  1. 1.Division of Cardiovascular and Thoracic Surgery, Department of SurgeryDuke University Medical CenterDurhamUSA

Personalised recommendations